| HS Code | 659274 |
| Brand Name | PROTESCAL Inj. |
| Active Ingredient | Calcium chloride |
| Formulation | Injection |
| Route Of Administration | Intravenous |
| Indications | Treatment of hypocalcemia, calcium channel blocker overdose, hyperkalemia, magnesium toxicity |
| Concentration | 10% (100 mg/mL) |
| Appearance | Clear, colorless solution |
| Dosage Form | Ampoule |
| Manufacturer | Hanlim Pharm. Co., Ltd. |
| Storage Conditions | Store below 25°C, protect from light |
| Packaging | Ampoules, typically 10 mL each |
| Country Of Origin | South Korea |
As an accredited PROTESCAL Inj. factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | PROTESCAL Inj. is packaged in a white and blue box containing 10 ampoules, each with 4ml of injectable solution. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for PROTESCAL Inj.: Fits approximately 60,000 vials securely packed, maintaining temperature and safety standards for transport. |
| Shipping | PROTESCAL Inj. should be shipped in accordance with cold chain requirements, maintaining a temperature between 2°C and 8°C. The product must be protected from light and handled with care. Use insulated packaging and include sufficient refrigerant packs to ensure temperature stability during transportation. Deliver promptly to preserve product integrity. |
| Storage | PROTESCAL Inj. should be stored at a controlled room temperature, ideally between 1°C and 30°C, away from direct sunlight, moisture, and excessive heat. The product should be kept in its original packaging to protect it from light and contamination. It must be stored out of reach of children and should not be used beyond its expiration date. |
| Shelf Life | The shelf life of PROTESCAL Inj. is 36 months from the date of manufacture when stored as recommended. |
PROTESCAL Inj. is a specialized chemical raw material developed for high-performance and safety-driven industrial applications. As the original manufacturer, we supply this ingredient to several well-regulated downstream sectors, where it addresses precise functional roles in finished product development. Below we provide in-depth insights into real-world usage across our core customer segments, focusing on industry-specific standards, formulation ratios, process integration points, and the major types of products produced using our material.
Veterinary injectable drug manufacturers utilize PROTESCAL Inj. as a controlled-release excipient and stabilizing agent in water-based and oil-based suspension formulations for livestock health products. Its defined role in parenteral drug manufacturing responds to authorities demanding multi-level batch traceability and targeted release kinetics. The consistency and regulatory pedigree of our ingredient has made it a recognized component in animal health injections, including those administered under farm and veterinary supervision. Customers adjust amounts based on the solubility and pharmacokinetic profiles of different APIs.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
PROTESCAL Inj. is used by downstream biologics manufacturers for its particle suspension and isotonicity properties in vaccine adjuvant blends and injectable protein preparations. Stringent compliance with pharmacopeial monographs and clinical trial batch documentation are required in this segment. Process engineers focus on preventing protein aggregation and maintaining excipient homogeneity in large-scale bioreactor-fed fill-finish lines. Typical dosages depend on the immunogen or protein concentration and desired release profiles. Traceability and reproducibility are ensured through extensive documentation and testing at every stage.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Ophthalmic manufacturers incorporate PROTESCAL Inj. to control osmolality and prevent precipitation or phase separation in sterile injectable and irrigating solutions used during surgical procedures. This requires compliance with pharmacopeial and ISO standards for injectable ophthalmics, as well as stability data for extended shelf-life. In practice, production engineers incorporate this material into solutions destined for both pre-filled syringes and intraoperative irrigation, optimizing concentration according to the salt content and target physiologic osmolarity. Downstream QC includes particulates, clarity, and ionic content analysis to guarantee regulatory conformance and patient safety.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Manufacturers of medical dialysate fluids rely on PROTESCAL Inj. to regulate ionic strength and maintain chemical stability in hemodialysis and peritoneal dialysis concentrates. Patients undergoing dialysis require tightly controlled fluid compositions free from particulate contamination, necessitating supplier compliance with a range of international and country-specific medical device standards. Blending engineers dose our ingredient into concentrate preparation tanks, verifying final characteristics such as osmolality and ion balance as specified by clinical protocols. Batch records include both in-process and release testing to ensure product consistency and patient safety.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Intravenous nutrition solution manufacturers use PROTESCAL Inj. as a stabilizer for multi-component parenteral formulas, particularly in total parenteral nutrition (TPN) blends for hospital and clinical settings. This application requires strict adherence to national pharmacopeial requirements for injectable nutritionals and stipulates traceable supply chains under cGMP environments. Blending technicians optimize the ingredient concentration to reduce precipitation risks and ensure compatibility with vitamins, trace elements, and amino acids throughout the product’s shelf life. Batch deployment coincides with sterility assurance and intensive inspection under in-house and inspection-agency protocols.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Competitive PROTESCAL Inj. prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618018036652 or mail to sales6@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8618018036652
Email: sales6@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Years of hands-on work in chemical manufacturing show where real value lies. PROTESCAL Inj. came about after seeing daily risks operators take and walking the factory floor with safety in mind. Its purpose isn’t to look good in technical documents; it’s to make injections practical and safer in real workplaces. We make and handle thousands of tons of process chemicals every year, and the insight comes from real spill responses and hours spent diagnosing equipment fouls or dosing irregularities. Customers and fellow engineers want more than statistics: they want to know how a product changes their workday and solves headaches that come with bulk dosing, reactivity, and maintenance.
The PROTESCAL Inj. line grows out of practical engineering experience, not trends. It comes as a liquid concentrate that targets corrosion, fouling, and scale buildup—identified by our technicians as the three main causes of plant shutdowns and extra maintenance cycles in dosing-managed processing lines. PROTESCAL Inj. runs in dosing systems calibrated from 0.5 to 2.5 L/h, fitting into the standard industrial peristaltic and diaphragm pump setups found in both automated and manual injection skid layouts.
Many customers ask about the numbers and regulatory spec lines, but our experience shows real differentiation happens elsewhere. Formulation is purpose-built: raw ingredient selection focuses on thermal and chemical stability under hot, variable pH waters—from power station boilers above 100°C to food and beverage recirculating systems exposed to fluctuating organic loads. Batch consistency matters; we run real-time, on-line QC for each batch and batch logs go back seven years, with every single drum traceable to the minute of manufacture. That traceability solves puzzled maintenance meetings when shutdowns occur months after a delivery, letting engineers see root cause, not conjecture.
Dosing PROTESCAL Inj. means fewer operator interventions. Traditional blends break down with time, requiring frequent adjustment and risking localized overdosage—this weakens pipe walls, clogs strainers, and creates sleepless nights for site managers. Operators using our injection lines report longer intervals between trouble calls, with most shifts moving from daily manual checks to automated data logging. We have tailored viscosity and density profiles to prevent pump cavitation and erratic dosing: no foaming or streaking in site glass or stickage in lines to clean out. Over years, we’ve seen our own staff spend less time unclogging injection lances, cutting downtime by half compared with non-specialized blends.
Another message that comes from spending time troubleshooting at customer sites: standard chemical lines rarely hold up when faced with fluctuating supply tanks or line pressure drops. PROTESCAL Inj. holds up when the inlet water jumps from 40 to 85 degrees or when conductivity swings push dosing controls to the edge. Additives in PROTESCAL Inj. buffer against both sharp pH changes and intense turbulence, avoiding dose runaway and formation of solid precipitates. That means operators stay clear of dusty cleanup jobs and zero lost time to clogged sample points or dosing heads.
We do not manufacture PROTESCAL Inj. to check off industry buzzwords. Large-scale and pilot feedback from process operators, not sales departments, drove the change. Dispatching field engineers every quarter lets us document long-term asset wear under true factory conditions instead of lab glassware. Comparing to generic corrosion inhibitors or scale preventers, PROTESCAL Inj. resists hydrolysis and chemical breakdown even when left stagnant in dosing lines for weeks—a common downtime scenario, especially in seasonal or batch industries.
A main reason plants switch comes down to visible difference after months of use. In boiler feed, cooling towers, and heat exchanger fields, PROTESCAL Inj. keeps build-up off metal surfaces and inhibits pitting. Water test logs from actual users show lower dissolved metals and a slow-down in scale development, especially where local water chemistry varies by season. Some try to match this by raising dose levels, but that invites its own pain: increased fouling and unnecessary chemical exposure for site teams. Years of inspection photos, not just internal data, show lines and heat exchangers lasting longer before mechanical cleaning—sometimes double the current cleaning interval.
Plants handle unexpected shut-ins, power drops, and sudden changes in flow. If a chemical blend can’t rebound from these, line fouling and component damage rises. Our team designed PROTESCAL Inj. both for steady-state dosing and for use in feed-forward systems where demand jumps minute to minute. Production batches use ingredients shown to withstand both acidic and alkaline upstream excursions—the most common cause of conventional additive breakdown. Failures usually stem from unseen side reactions under variable flow or temperature; we watched this happen over years and formulated away from those triggers.
In food and pharma lines, system audits highlight another need: avoiding anything that taints the product while keeping lines free of growth or buildup. PROTESCAL Inj. gets tested under both simulated and real processing flows for residue and reaction byproducts. QA teams monitor rinse-downs post-dosing to check for possible trace carryover. Where dosing systems tie into automatic wash-down cycles, PROTESCAL’s detergent compatibility stands out: operators can flush lines using standard cleaning solutions without risking thickened gels or stubborn deposits, a recurring issue with some blends sourced to price over reliability.
A large part of daily work is making chemical handling less hazardous for crews. PROTESCAL Inj. was formulated in response to frequent requests for reduced operator risk and easier cleanup. Viscosity control means less splashing during drum changes or transfer. Low odor and minimal fume release reduce the need for full-face protection in well-ventilated spaces, improving compliance with evolving PPE policies. Empty drums are easy to rinse—no slippery residue that creates slip-and-trip hazards or gum up return transport.
The practical benefit: less downtime for safety audits and fewer corrective actions for chemical mismanagement. In industries that must document every drum's fate, simplicity in disposal matters. QC reports back from users found that most spills clean up with a water rinse and absorbent pad; no stubborn films requiring repeated scrubbing. Over years, records show lost-time injuries tied to chemical transfers have dropped—less spill volume, fewer skin irritation claims, and more predictable handling on rainy or humid days in unconditioned plants.
As compliance obligations grow, especially around wastewater and workplace exposure, chemical blends must track precise source data, composition, and batch history. PROTESCAL Inj. draws from a long data archive and active sourcing policies, so every batch maps back to lot-level QA. Environmental teams can see ongoing trends in downstream wastewater and operational records align with declared discharge characteristics. We work with teams on documentation for both scheduled audits and event-driven investigations. For food, beverage, and pharmaceutical lines, PROTESCAL matches migration and contamination guidelines, and audit-ready declarations run batch-by-batch.
Many operators worry about the cost of switching blends, but historical process records actually show consumption stabilizes over time; sites spend less on emergency repairs and filtering, less on out-of-spec product that must be discarded or reprocessed. Our team sees product reliability play out in environmental records: wastewater analysis after a switch to PROTESCAL Inj. found lower residual contaminants, aiding in hitting stricter discharge targets. Additive selection avoids restricted substances—so environmental risk teams spend less time screening for legacy concerns in older formulations.
Field input drives every product change. A dozen prototype batches never left the factory because customer plant managers or dosing operators said the mix didn’t deliver on an identified plant pain point. We invite critical feedback. Facility walk-throughs with operations teams—and many cups of coffee poured while sifting through maintenance logs—helped us ditch abstraction in favor of direct answers to real problems.
Ongoing cooperation with end users steers upgrades from minor tweaks to formulation overhaul. We log every return, every documented batch issue, and every field fix, and those reports feed updates back to our process engineers. The design of the ‘Inj.’ line is not static; updating a recipe based on a sharp ammonia spike in municipal water, or a biofilm outbreak at a beverage bottler, can mean the difference between a one-off fix and a recurring, proactive improvement. Recordkeeping lets engineers check new additives against field history, reducing trial-and-error downtime for operators.
Many chemical options exist for water treatment, corrosion inhibition, and scale prevention, but not all address persistent field problems. PROTESCAL Inj. grows from our own experience handling chemicals in busy plants. The main goal is to shape a workflow where plant managers, operators, and maintenance teams can trust what they’re dosing—without second-guessing every surplus drum or wondering if today’s batch matches last year’s.
The line between lab data and plant reality can be wide. The goal is to close that gap with credible, consistent performance and accessible technical support. Site teams need answers: what’s in the tank, how much to dose, and what to expect at inspection. Our factory staff and field engineers provide straight answers about batch composition, likely deposit outcomes, and support plant audits regardless of compliance body or regulatory framework.
Finally, the most valuable feedback comes unscripted, from people elbow-deep in daily operations. Shifting to PROTESCAL Inj. means tangible change: less downtime, reduced manual intervention, and easier compliance. We keep a standing invitation for operators and maintenance chiefs to challenge, question, and suggest further changes—direct from the source, not filtered through sales chains.
Producing chemicals like PROTESCAL Inj. is more than blending ingredients to match a spec. It’s the sum of years spent tracing failures in heat exchangers, investigating blocked dosing pumps, and documenting the reasons behind unexpected shutdowns. The progress comes from relentless feedback and a commitment to adapt to changing site needs, safety standards, and environmental expectations. As process industries move forward, the demand for products that perform under real working conditions grows stronger. PROTESCAL Inj. stands as the outcome of those shared demands: reliable chemistry, proven improvement, and fewer complications for the people who spend their time on the ground, making things work.